Conviction
$ Value
$253K
Shares
14,124
Price
$18
Filed
Feb 12
▶ Why this score? (6/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Garnett Timothy John
Title
—
CIK
0001998937
Roles
Transaction Details
Transaction Date
2026-02-10
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
14,124
Footnotes
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.76 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote. | The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power.
Filing Info
Garnett Timothy John's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | MPLT | ▲ | $253K ★ |
| 2025-10-27 | MPLT | A | $0 |
| 2025-10-27 | MPLT | A | $0 |
Other Insiders at MPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pavlov George | $441K | — | 2026-02-20 |
|
Kroeger Christopher A.
Chief Executive Officer
|
— | $521K | 2026-04-16 |
|
GILLIS JONATHAN
CAAO and PAO
|
— | $96K | 2026-04-15 |
|
Lillie James Woodruff
Chief Scientific Officer
|
— | $123K | 2026-04-16 |
|
Hanson Kristopher
General Counsel
|
— | $49K | 2026-04-16 |
| Malenka Robert C. | — | $1.6M | 2026-04-15 |
|
Foff Erin Pennock
Chief Medical Officer
|
— | $87K | 2026-04-16 |
|
Kreitzer Anatol
Chief Discovery Officer
|
— | $88K | 2026-04-15 |
|
Setia Vishwas
Chief Financial Officer
|
— | $79K | 2026-04-16 |